Streetbeat News

Products Services

CLDX

Celldex Therapeutics Inc (NASDAQ:CLDX) released positive topline results from its Phase 2 trial of barzolvolimab in patients with moderate to severe chronic spontaneous urticaria (CSU). The drug achieved the primary efficacy endpoint and demonstrated rapid, durable, and clinically meaningful responses. The treatment was well tolerated with a favorable safety profile. Following the news, CLDX shares are up 25.00% at $32.48.

Portfolio Pulse from Vandana Singh

November 06, 2023 | 3:27 pm

EVAX

Evaxion Biotech A/S (NASDAQ:EVAX) has shared the latest phase 2 clinical data for its lead clinical asset, EVX-01, in a webinar with key opinion leader Adnan Khattak. The data confirms the promising results of the phase 1 trial. The company believes that its AI-Immunology™ platform, which powers EVX-01, has the potential to revolutionize cancer treatment, particularly for malignant melanoma.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:13 pm

EWJ

EWY

META

Meta Platforms is rolling out more control over pricing for creators on Facebook and Instagram. The company is testing an invite-only holiday bonus for creators in the US, South Korea, and Japan, rewarding them for reels plays and photo views. Instagram subscriptions have surpassed 1 million, and Meta is introducing new promotional tools to help creators grow their subscriber communities. The company is also expanding access to Facebook subscriptions and Instagram gifts to more creators globally.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:10 pm

EWJ

EWY

META

Meta Platforms is testing a new invite-only holiday bonus on Instagram for creators in the U.S., South Korea, and Japan, rewarding them for reels plays and photo views. The company is also adding more ways for followers to subscribe via Reels and Stories on Facebook. Instagram subscriptions have surpassed 1 million, and Meta is waiving subscription fees for creators on both platforms. The company is also expanding access to Instagram gifts to creators in multiple countries.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:09 pm

H

Hyatt Hotels Corporation (NYSE:H) and Parks Hospitality Holdings (PHH) have announced a collaboration to expand Hyatt's brand footprint in Mexico with the development of four new properties across key destinations, including Mexico City, Los Cabos, and Cancun. The new properties are expected to open starting 2024 and will include two Grand Hyatt hotels, a new select-service offering near the Cancun International Airport, and the debut of the Park Hyatt brand in Cancun. The collaboration reflects a strong development pipeline driven by sustained demand for leisure and luxury travel.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:02 pm

APLS

Citron Research has released a report on Apellis Pharmaceuticals (APLS), stating that the company's successful days are over due to concerns over its drug, Syfovre. The drug, used for treating Geographic Atrophy, has been linked to retinal vasculitis, a side effect that has caused the company's stock to drop. Despite these reports, Apellis continues to stand by the safety of Syfovre.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:58 pm

NOTE

FiscalNote (NYSE:NOTE), an AI-driven enterprise SaaS technology provider, has expanded its global policy coverage to include China. The new offering covers China's national and provincial legislative and regulatory policy developments. This addition marks the latest enhancement to FiscalNote's Global Policy Dashboard, which already covers over 80 countries. The expansion aims to provide customers with comprehensive monitoring, tracking, news, and analysis of legislative and regulatory activity in China.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:49 pm

APD

VGK

XOM

Air Products announced plans to build Europe's largest blue hydrogen plant in Rotterdam, the Netherlands, expected to be operational by 2026. The plant will serve ExxonMobil's Rotterdam refinery and other customers via Air Products' hydrogen pipeline network. The project is part of long-term agreements with ExxonMobil and the Dutch State. The plant will also feature a carbon capture and CO2 treatment facility, which will help reduce Air Products' direct emissions and contribute to meeting the Dutch National Climate Agreement targets.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:41 pm

VERB

Verb Technology Company Inc (NASDAQ:VERB) shares surged by 24% following the announcement of new technology integrations for its MARKET.live platform. These integrations will allow seamless connectivity with existing ecommerce solutions of vendors, improving inventory management and synchronization. The company has added 10 high-profile brands in just one week, enhancing the shopping experience for MARKET.live users.

Portfolio Pulse from Henry Khederian

November 06, 2023 | 2:39 pm

MULN

Mullen has received EPA certification for its commercial Class 1 and Class 3 EV vehicles, a key milestone for selling vehicles in the U.S. The Class 3 EV cab chassis truck received EPA certification on Sept. 22, 2023, and Class 1 vehicle production began on Nov. 2, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:33 pm